BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang Z, Shen Q, Xie H, Zhou X, Li J, Feng J, Liu H, Wang W, Zhang S, Ni S. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Oncotarget 2016;7:46253-62. [PMID: 27323829 DOI: 10.18632/oncotarget.10086] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Dominiak A, Chełstowska B, Olejarz W, Nowicka G. Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions. Cancers (Basel) 2020;12:E1232. [PMID: 32422889 DOI: 10.3390/cancers12051232] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
2 Kobayashi PE, Lainetti PF, Leis-Filho AF, Delella FK, Carvalho M, Cury SS, Carvalho RF, Fonseca-Alves CE, Laufer-Amorim R. Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway. Front Vet Sci 2020;7:561212. [PMID: 33324695 DOI: 10.3389/fvets.2020.561212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Fan L, An G, Wang S, Chen X, Liu Y, Liu Z, Ma Q, Wang J. Circular RNA Expression Profiling and Selection of Key Circular RNAs in the Hypothalamus of Heat-Acclimated Rats. Front Physiol 2019;10:1112. [PMID: 31555146 DOI: 10.3389/fphys.2019.01112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 McQuerry JA, Chen J, Chang JT, Bild AH. Tepoxalin increases chemotherapy efficacy in drug-resistant breast cancer cells overexpressing the multidrug transporter gene ABCB1. Transl Oncol 2021;14:101181. [PMID: 34298440 DOI: 10.1016/j.tranon.2021.101181] [Reference Citation Analysis]
5 Floresta G, Cilibrizzi A, Abbate V, Spampinato A, Zagni C, Rescifina A. FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets. Data Brief 2019;22:471-83. [PMID: 30619925 DOI: 10.1016/j.dib.2018.12.047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Luo X, Zhao X, Cheng C, Li N, Liu Y, Cao Y. The implications of signaling lipids in cancer metastasis. Exp Mol Med 2018;50:1-10. [PMID: 30242145 DOI: 10.1038/s12276-018-0150-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
7 Wu G, Zhang Z, Tang Q, Liu L, Liu W, Li Q, Wang Q. Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma. J Cell Physiol 2020;235:3776-89. [DOI: 10.1002/jcp.29272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Wang L, Wei Q, Zhang M, Chen L, Li Z, Zhou C, He M, Wei M, Zhao L. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients. Int Immunopharmacol 2020;87:106795. [PMID: 32707495 DOI: 10.1016/j.intimp.2020.106795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Antúnez-argüelles E, Robles-gómez E. New insights in the opening mechanism of the heart-type fatty acid binding protein in its apo form (apo-FABP3). Struct Chem 2020;31:619-29. [DOI: 10.1007/s11224-019-01446-2] [Reference Citation Analysis]
10 Schwarz R, Ramer R, Hinz B. Targeting the endocannabinoid system as a potential anticancer approach. Drug Metab Rev 2018;50:26-53. [PMID: 29390896 DOI: 10.1080/03602532.2018.1428344] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
11 Wang Y, Ku W, Liu C, Cheng Y, Chien C, Chang K, Huang C. Supplementation of Probiotic Butyricicoccus pullicaecorum Mediates Anticancer Effect on Bladder Urothelial Cells by Regulating Butyrate-Responsive Molecular Signatures. Diagnostics 2021;11:2270. [DOI: 10.3390/diagnostics11122270] [Reference Citation Analysis]
12 Mallick R, Basak S, Duttaroy AK. Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers. Prog Lipid Res 2021;83:101116. [PMID: 34293403 DOI: 10.1016/j.plipres.2021.101116] [Reference Citation Analysis]
13 Liu G, Ding M, Chiuve SE, Rimm EB, Franks PW, Meigs JB, Hu FB, Sun Q. Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study. Arterioscler Thromb Vasc Biol 2016;36:2259-67. [PMID: 27609367 DOI: 10.1161/ATVBAHA.116.308320] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
14 Mathis C, Lascombe I, Monnien F, Bittard H, Kleinclauss F, Bedgedjian I, Fauconnet S, Valmary-Degano S. Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up. BMC Cancer 2018;18:1239. [PMID: 30526555 DOI: 10.1186/s12885-018-5137-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
15 Corn KC, Windham MA, Rafat M. Lipids in the tumor microenvironment: From cancer progression to treatment. Prog Lipid Res 2020;80:101055. [PMID: 32791170 DOI: 10.1016/j.plipres.2020.101055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
16 Huang M, Narita S, Inoue T, Koizumi A, Saito M, Tsuruta H, Numakura K, Satoh S, Nanjo H, Sasaki T, Habuchi T. Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production. Oncotarget 2017;8:111780-94. [PMID: 29340091 DOI: 10.18632/oncotarget.22908] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
17 Zhong CQ, Zhang XP, Ma N, Zhang EB, Li JJ, Jiang YB, Gao YZ, Yuan YM, Lan SQ, Xie D, Cheng SQ. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. Cancer Med 2018;7:2629-40. [PMID: 29733540 DOI: 10.1002/cam4.1511] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
18 Liu T, Fang P, Han C, Ma Z, Xu W, Xia W, Hu J, Xu Y, Xu L, Yin R, Wang S, Zhang Q. Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer. J Cell Mol Med 2020;24:711-21. [PMID: 31746108 DOI: 10.1111/jcmm.14779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
19 Hua TNM, Kim MK, Vo VTA, Choi JW, Choi JH, Kim HW, Cha SK, Park KS, Jeong Y. Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPARγ activation exerting cancer growth suppression. EBioMedicine 2019;41:134-45. [PMID: 30755372 DOI: 10.1016/j.ebiom.2019.02.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
20 Xu D, Zhang J, Xu H, Zhang Y, Chen W, Gao R, Dehmer M. Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data. BMC Genomics 2020;21:650. [PMID: 32962626 DOI: 10.1186/s12864-020-07038-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang Z, Shen W, Li X, Feng Y, Qian K, Wang G, Gao Y, Xu X, Zhang S, Yue L, Cao J. The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells. Drug Des Devel Ther 2020;14:3099-110. [PMID: 32801648 DOI: 10.2147/DDDT.S242557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang Y, Yuan Z, Shen R, Jiang Y, Xu W, Gu M, Gu X. Identification of biomarkers predicting the chemotherapeutic outcomes of capecitabine and oxaliplatin in patients with gastric cancer. Oncol Lett 2020;20:290. [PMID: 33029206 DOI: 10.3892/ol.2020.12153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Gyamfi J, Yeo JH, Kwon D, Min BS, Cha YJ, Koo JS, Jeong J, Lee J, Choi J. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer 2021;7:129. [PMID: 34561446 DOI: 10.1038/s41523-021-00324-7] [Reference Citation Analysis]
24 Bowden M, Nadal R, Zhou CW, Werner L, Barletta J, Juanpere N, Lloreta J, Hernandez-Llodrà S, Morote J, de Torres I, Orsola A, Cejas P, Long H, Bellmunt J. Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer. Sci Rep 2020;10:20135. [PMID: 33208770 DOI: 10.1038/s41598-020-76904-7] [Reference Citation Analysis]
25 Chen X, Hu SL, Feng Y, Li P, Mao QS, Xue WJ. Expression of Fatty Acid-Binding Protein-3 in Gastrointestinal Stromal Tumors and Its Significance for Prognosis. J Surg Res 2021;260:462-6. [PMID: 33272594 DOI: 10.1016/j.jss.2020.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Hermanowicz JM, Kwiatkowska I, Pawlak D. Important players in carcinogenesis as potential targets in cancer therapy: an update. Oncotarget 2020;11:3078-101. [PMID: 32850012 DOI: 10.18632/oncotarget.27689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Zang WJ, Wang ZN, Hu YL, Huang H, Ma P. Expression of fatty acid-binding protein-4 in gastrointestinal stromal tumors and its significance for prognosis. J Clin Lab Anal 2021;35:e24017. [PMID: 34558731 DOI: 10.1002/jcla.24017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Li D, Yang W, Zhang Y, Yang JY, Guan R, Xu D, Yang MQ. Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature. BMC Med Genomics 2018;11:106. [PMID: 30453959 DOI: 10.1186/s12920-018-0413-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
29 Ni M, Liu X, Meng Z, Liu S, Jia S, Liu Y, Zhou W, Wu J, Zhang J, Guo S, Li J, Wang H, Zhang X. A bioinformatics investigation into the pharmacological mechanisms of javanica oil emulsion injection in non-small cell lung cancer based on network pharmacology methodologies. BMC Complement Med Ther 2020;20:174. [PMID: 32503508 DOI: 10.1186/s12906-020-02939-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Cordero A, Kanojia D, Miska J, Panek WK, Xiao A, Han Y, Bonamici N, Zhou W, Xiao T, Wu M, Ahmed AU, Lesniak MS. FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis. Oncogene 2019;38:6445-60. [PMID: 31324889 DOI: 10.1038/s41388-019-0893-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
31 Guo Y, Wang ZW, Su WH, Chen J, Wang YL. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma. Biomed Res Int 2020;2020:4145164. [PMID: 32685482 DOI: 10.1155/2020/4145164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Assi M, Kenawi M, Ropars M, Rébillard A. Interleukin-6, C/EBP-β and PPAR-γ expression correlates with intramuscular liposarcoma growth in mice: The impact of voluntary physical activity levels. Biochem Biophys Res Commun 2017;490:1026-32. [PMID: 28668397 DOI: 10.1016/j.bbrc.2017.06.158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Yang J, Gao F, Xu X, Wang Y, Zhu S. Targeting protein for Xenopus kinesin-like protein 2 knockdown enhances radiation sensitivity of human lung squamous carcinoma cell. Clin Exp Pharmacol Physiol 2017;44:1060-8. [PMID: 28636807 DOI: 10.1111/1440-1681.12800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Xiao J, Liu A, Lu X, Chen X, Li W, He S, He B, Chen Q. Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma. Sci Rep. 2017;7:2027. [PMID: 28515486 DOI: 10.1038/s41598-017-02290-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
35 Zhou Q, Yang H, Pan H, Pan H, Zhou J. Exosomes isolated from the miR-215-modified bone marrow mesenchymal stem cells protect H2O2-induced rat myoblasts via the miR-215/FABP3 pathway. Exp Mol Pathol 2021;119:104608. [PMID: 33503452 DOI: 10.1016/j.yexmp.2021.104608] [Reference Citation Analysis]
36 Hsu YL, Hung JY, Lee YL, Chen FW, Chang KF, Chang WA, Tsai YM, Chong IW, Kuo PL. Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis. Oncotarget 2017;8:104831-54. [PMID: 29285217 DOI: 10.18632/oncotarget.21022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
37 Zhang Y, Zhang W, Xia M, Xie Z, An F, Zhan Q, Tian W, Zhu T. High expression of FABP4 in colorectal cancer and its clinical significance. J Zhejiang Univ Sci B 2021;22:136-45. [PMID: 33615754 DOI: 10.1631/jzus.B2000366] [Reference Citation Analysis]
38 Bandyopadhayaya S, Ford B, Mandal CC. Cold-hearted: A case for cold stress in cancer risk. J Therm Biol 2020;91:102608. [PMID: 32716858 DOI: 10.1016/j.jtherbio.2020.102608] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
39 Furuhashi M. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases. J Atheroscler Thromb 2019;26:216-32. [PMID: 30726793 DOI: 10.5551/jat.48710] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
40 Kim DS, Kwon NS, Yun HY. Leucine rich repeat LGI family member 3: Integrative analyses reveal its prognostic association with non-small cell lung cancer. Oncol Lett 2019;18:3388-98. [PMID: 31452819 DOI: 10.3892/ol.2019.10648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Malvia S, Bagadi SAR, Pradhan D, Chintamani C, Bhatnagar A, Arora D, Sarin R, Saxena S. Study of Gene Expression Profiles of Breast Cancers in Indian Women. Sci Rep 2019;9:10018. [PMID: 31292488 DOI: 10.1038/s41598-019-46261-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
42 Jung Y, Cho SM, Kim S, Cheong JH, Kwon HJ. Functional inhibition of fatty acid binding protein 4 ameliorates impaired ciliogenesis in GCs. Biochem Biophys Res Commun 2021;539:28-33. [PMID: 33418190 DOI: 10.1016/j.bbrc.2020.12.083] [Reference Citation Analysis]
43 McKillop IH, Girardi CA, Thompson KJ. Role of fatty acid binding proteins (FABPs) in cancer development and progression. Cell Signal 2019;62:109336. [PMID: 31170472 DOI: 10.1016/j.cellsig.2019.06.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
44 Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-jensen T, Katz B. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma. Virchows Arch 2017;471:355-62. [DOI: 10.1007/s00428-017-2172-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Peng D, Gu B, Ruan L, Zhang X, Shu P. Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer. Biomed Res Int 2020;2020:9780981. [PMID: 32352015 DOI: 10.1155/2020/9780981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]